VREOF · Vireo Growth Inc.
Market Cap
$521.42M
Shares
48.06M
VREOF metrics
52 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$12.55
Market cap
$521.42M
Price action
19 metricsPrice change (1W)
+18.4%
Price change (30D)
+25.4%
Price change (3M)
-1.3%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
47.9%
Beta
—
RSI (14D)
80.3
Price vs SMA 50
+22.4%
Price vs SMA 200
—
Avg volume (3M)
31,290
Relative volume
4.5
Average dollar volume
$339,415
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
48.06M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.0×
reciprocal yield 98.1%
P / book
1.2
reciprocal yield 84.9%
FCF yield
-22.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
19.9
reciprocal yield 5.0%
Earnings yield
-12.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-11
Profitability
9 metricsGross margin
48.6%
Operating margin
0.3%
Trailing 12 months
Net margin
-13.1%
Gross profit (TTM)
$248.90M
Operating profit (TTM)
$1.65M
Net income (TTM)
−$67.11M
Trailing 12 months
Diluted EPS (TTM)
$-1.90
FCF margin
-22.7%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+335.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$511.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+141.9%
Year over year · more shares
Revenue CAGR (3Y)
+53.3%
Revenue CAGR (5Y)
+40.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-15.2%
Return on assets
-5.3%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$25.76M
Free cash flow (TTM)
−$116.31M
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$122.70M
Total assets
$1.27B
Total debt
$58.21M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$26.21M
Capital expenditures (TTM)
$142.52M
R&D (TTM)
—
SG&A (TTM)
$163.79M
Stock compensation (TTM)
$27.51M
R&D / revenue
—
Stock compensation / revenue
5.4%
Ownership (13F)
3 metrics13F filers
0
13F filer change QoQ
-1
Institutional ownership
—
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
71 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—